Skip to content
intercept-t2d
intercept-t2d
  • The project
  • Ambition
  • Partners
  • News
  • Clinical Trial
  • Extranet
  • Contact
  • The project
  • Ambition
  • Partners
  • News
  • Clinical Trial
  • Extranet
  • Contact

INTERCEPT-T2D featured in Research & Development Magazine

You are here:
  1. Home
  2. News
  3. INTERCEPT-T2D featured in Research &…

An article about INTERCEPT-T2D has been published in Research & Development Magazine on 28 March 2025.

The feature highlights the project and its research activities for an international life sciences and innovation audience.

Read the full article:
Early action on inflammatory T2D – RD Magazine

 

 

Post navigation

PreviousPrevious post:Aldolase-regulated G3BP1/2+ condensates control insulin mRNA storage in beta cellsNextNext post:INTERCEPT-T2D Clinical Trial Launches in the EU centers

Still have any questions?
Contact us!

Scientific Coordinator:

Nicolas Venteclef,
Inserm, France

Project Manager:

Stéphanie Rémola,
Inserm-Transfert, France

INTERCEPT-T2D
  • The project
  • Ambition
  • Partners
  • News
  • Clinical Trial
  • Extranet
  • Contact
logo-union-europeenne

Intercept-T2D project is funded by the European Union under the Horizon Europe Programme (Grant Agreement No 101095433)

  • Legal notice
  • Privacy policy